AU4385393A - Arterial introduction of myoblasts - Google Patents
Arterial introduction of myoblastsInfo
- Publication number
- AU4385393A AU4385393A AU43853/93A AU4385393A AU4385393A AU 4385393 A AU4385393 A AU 4385393A AU 43853/93 A AU43853/93 A AU 43853/93A AU 4385393 A AU4385393 A AU 4385393A AU 4385393 A AU4385393 A AU 4385393A
- Authority
- AU
- Australia
- Prior art keywords
- myoblasts
- arterial
- introduction
- arterial introduction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Developmental Biology & Embryology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Microbiology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US891438 | 1978-03-29 | ||
US89143892A | 1992-05-29 | 1992-05-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4385393A true AU4385393A (en) | 1993-12-30 |
Family
ID=25398185
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU43853/93A Abandoned AU4385393A (en) | 1992-05-29 | 1993-05-20 | Arterial introduction of myoblasts |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4385393A (en) |
WO (1) | WO1993024151A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5538722A (en) * | 1989-06-13 | 1996-07-23 | Stanford University | Isolation, growth, differentiation and genetic engineering of human muscle cells |
EP0751987A1 (en) * | 1994-03-31 | 1997-01-08 | Diacrin, Inc. | Genetically modified cells for use in transplantation |
GB9419048D0 (en) * | 1994-09-20 | 1994-11-09 | Watt Diana J | Treatment of muscular disorders |
FR2746109B1 (en) | 1996-03-12 | 1998-04-17 | Rhone Poulenc Rorer Sa | ENVIRONMENT FOR THE CONSERVATION OF BIOLOGICAL MATERIAL |
EP0896542A1 (en) * | 1996-03-29 | 1999-02-17 | Universite Laval | Method of restoring a functional protein in a tissue by cell transplantation |
US6110459A (en) * | 1997-05-28 | 2000-08-29 | Mickle; Donald A. G. | Transplants for myocardial scars and methods and cellular preparations |
JP2010514050A (en) * | 2006-12-18 | 2010-04-30 | トムソン ライセンシング | Self test equipment components |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5087244A (en) * | 1989-01-31 | 1992-02-11 | C. R. Bard, Inc. | Catheter and method for locally applying medication to the wall of a blood vessel or other body lumen |
-
1993
- 1993-05-20 WO PCT/US1993/004812 patent/WO1993024151A1/en active Application Filing
- 1993-05-20 AU AU43853/93A patent/AU4385393A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1993024151A1 (en) | 1993-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3599293A (en) | Hand-actuated retention catheter | |
AU5015893A (en) | Atherectomy catheter | |
AU4285889A (en) | Preparation of catheter | |
AU7190994A (en) | Tunnelling catheter | |
AU2751692A (en) | Ambulatory doll | |
AU6967991A (en) | Catheter atherotome | |
AU6152590A (en) | Valvulotome catheter | |
AU6824390A (en) | Catheter | |
AU7867994A (en) | Hemofiltration of mediator-related diseases | |
AU3556793A (en) | Inflatable catheter system | |
AU4772493A (en) | Sulfo-derivatives of adenosine | |
AU3950193A (en) | Cannula | |
AU3733793A (en) | Iodine derivatives of tetrabenazyne | |
AU5184393A (en) | Substituted derivatives of diaminophthalimide | |
AU4385393A (en) | Arterial introduction of myoblasts | |
AU6723294A (en) | Use of simmondsine | |
AU3423693A (en) | Methods of terminating pregnancy | |
AU7185191A (en) | Oxidized variants of gm-csf | |
AU5371694A (en) | Use of the tarchonanthus camphoratus | |
PL310675A1 (en) | Application of ferrocene | |
AU6357890A (en) | Expression of alpha-macroglobulins | |
AU2480992A (en) | Preparation of peroxyacids | |
AU4419693A (en) | Micro-emulsion of dexniguldipin | |
ZA944577B (en) | Preparation of aminopropionitriles | |
GB2275266A8 (en) | Preparation of 2-methyl-3-aminobenzotrifluoride |